Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine versus erythropoietin in hospitalized traumatic brain injury patients
IRCT20190325043107N55Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine and erythropoietin in traumatic brain injury (TBI) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Level of consciousness. Started Mar 2025; status: completed.
02
Drugs
levocarnitineerythropoietin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20190325043107N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N55.